Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Published in: European Journal of Clinical Microbiology & Infectious Diseases 7/2010

01-07-2010 | Article

Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus

Authors: E. Guinoiseau, A. Luciani, P. G. Rossi, Y. Quilichini, S. Ternengo, P. Bradesi, L. Berti

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 7/2010

Login to get access

Abstract

This study was conducted to evaluate the antibacterial activity of Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus and investigate their effects at the cellular level. The mode of inhibition of both essential oils against S. aureus ATCC 6538P (CIP 53.156) was assessed by determining the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC). The effects of time and treatment dose on cell viability were determined by time-kill and bacteriolysis assays. Marked structural changes were observed by transmission electron microscopy (TEM). A bactericidal mode of inhibition was established for both essential oils, which rapidly reduced the cell viability of S. aureus at their MIC (5 mg·ml-1). No lysis occurred after treatments with the MIC and eight times the MIC of each essential oil. Invaginations of the plasmic membrane with thickenings of the cell wall as well as an aggregation of the cytoplasmic contents were observed in S. aureus cells treated with the MIC of both essential oils. These results suggest that the cytoplasmic membrane and the cell wall are involved in the toxic action of Inula graveolens and Santolina corsica essential oils.
Literature
1.
National Nosocomial Infections Surveillance System (2004) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485CrossRef
2.
CDC (2002) Staphylococcus aureus resistant to vancomycin—United States. JAMA 7:824–825
3.
Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan GE Jr, Tenover FC, Brown SD (2003) In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microb Drug Resist 9:389–393CrossRefPubMed
4.
Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, Clark N, Killgore G, O’Hara CM, Jevitt L, Patel JB, Bozdogan B (2004) Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 48:275–280CrossRefPubMed
5.
Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R (2009) Daptomycin therapy failure in an adolescent with methicillin resistant Staphylococcus aureus bacteremia. Pediatr Infect Dis J 28:445–447CrossRefPubMed
6.
Đordević S, Petrović S, Dobrić S, Milenković M, Vučićević D, Žižić S, Kukić J (2007) Antimicrobial, anti-inflammatory, anti-ulcer and anti-oxidant activities of Carlina acanthifolia root essential oil. J Ethnopharmacol 109:458–463CrossRefPubMed
7.
De Sousa AC, Alviano DS, Blank AF, Alves PB, Alviano CS, Gattass CR (2004) Melissa officinalis L. essential oil: antitumoral and antioxidant activities. J Pharm Pharmacol 56:677–681CrossRefPubMed
8.
Kumar A, Malik F, Bhushan S, Sethi VK, Shahi AK, Kaur J, Taneja SC, Qazi GN, Singh J (2008) An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells. Chem Biol Interact 171:332–337CrossRefPubMed
9.
Xiao Y, Yang FQ, Li SP, Hu G, Lee SMY, Wang YT (2008) Essential oil of Curcuma wenyujin induces apoptosis in human hepatoma cells. World J Gastroenterol 14:4309–4318CrossRefPubMed
10.
Jasicka-Misiak I, Lipok J, Nowakowska EM, Wieczorek PP, Mlynarz P, Kafarski P (2004) Antifungal activity of the carrot seed oil and its major sesquiterpene compounds. Z Naturforsch C 59:791–796PubMed
11.
Pinto E, Pina-Vaz C, Salgueiro L, Gonçalves MJ, Costa-de-Oliviera S, Cavaleiro C, Palmeira A, Rodriguez A, Martinez-de-Oliviera J (2006) Antifungal activity of the essential oil of Thymus puleigoides on Candida, Aspergillus and dermatophyte species. J Med Microbiol 55:1367–1373CrossRefPubMed
12.
Tavares AC, Gonçalves MJ, Cavaleiro C, Cruz MT, Lopes MC, Canhoto J, Salgueiro LR (2008) Essential oil of Daucus carota subsp. halophilus: composition, antifungal activity and cytotoxicity. J Ethnopharmacol 119:129–134CrossRefPubMed
13.
Burt S (2004) Essential oils: their antibacterial properties and potential applications in foods—a review. Int J Food Microbiol 94:223–253CrossRefPubMed
14.
Carson CF, Hammer KA, Riley TV (2006) Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19:50–62CrossRefPubMed
15.
Liu K, Rossi PG, Ferrari B, Berti L, Casanova J, Tomi F (2007) Composition, irregular terpenoids, chemical variability and antibacterial activity of the essential oil from Santolina corsica Jordan et Fourr. Phytochemistry 68:1698–1705CrossRefPubMed
16.
Rossi PG, Bao L, Luciani A, Panighi J, Desjobert JM, Costa J, Casanova J, Bolla JM, Berti L (2007) (E)-Methylisoeugenol and elemicin: antibacterial components of Daucus carota L. essential oil against Campylobacter jejuni. J Agric Food Chem 55:7332–7336CrossRefPubMed
17.
Rossi PG, Berti L, Panighi J, Luciani A, Maury J, Muselli A, De Rocca SD, Gonny M, Bolla JM (2007) Antibacterial action of essential oils from Corsica. J Essent Oil Res 19:176–182
18.
Bianchini A, Tomi P, Costa J, Bernardini AF (2001) Composition of Helichrysum italicum (Roth) G. Don fil. subsp. italicum essential oils from Corsica (France). Flavour Fragr J 16:30–34CrossRef
19.
Blanc MC, Muselli A, Bradesi P, Casanova J (2004) Chemical composition and variability of the essential oil of Inula graveolens from Corsica. Flavour Fragr J 19:314–319CrossRef
20.
Carson CF, Hammer KA, Riley TV (1995) Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). Microbios 82:181–185PubMed
21.
Cha JD, Jung EK, Kil BS, Lee KY (2007) Chemical composition and antibacterial activity of essential oil from Artemisia feddei. J Microbiol Biotechnol 17:2061–2065PubMed
22.
Klepser M, Ernst EJ, Russell EL, Ernst ME, Pfaller MA (1998) Influence of test conditions on antifungal time-kill curves results: proposal for standardized methods. Antimicrob Agents Chemother 42:1207–1212PubMed
23.
Viljoen A, Van Vuuren S, Ernst E, Klepser M, Demirci B, Baser H, Van Wyk BE (2003) Osmitopsis asteriscoides (Asteraceae)—the antimicrobial activity and essential oil composition of a Cape-Dutch remedy. J Ethnopharmacol 88:137–143CrossRefPubMed
24.
Carson CF, Mee BJ, Riley TV (2002) Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined par time-kill, lysis, leakage and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 46:1914–1920CrossRefPubMed
25.
National Commitee for Clinical Laboratory Standards (1999) Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A. NCCLS 19(18)
26.
Hammer KA, Carson CF, Riley TV (1996) Susceptibility of transient and skin flora to the essential oil of Melaleuca alternifolia (tea tree oil). Am J Infect Control 24:186–189CrossRefPubMed
27.
Garnier G, Bezanger-Beauquesne L, Debraux G (1961) Ressources médicinales de la flore Française. Vigot Frères Editeurs, Paris, vol. 2, pp 1358.
28.
Bolhmann F, Mahanta PK, Jakupovic J, Rastogi RC, Natu AA (1978) Naturally occurring terpene derivatives. 142. New sesquiterpene lactones from Inula species. Phytochemistry 17:1165–1168CrossRef
29.
Dorman HJD, Deans SG (2000) Antimicrobial agents from plants: antibacterial activity of plant volatile oils. J Appl Microbiol 88:308–316CrossRefPubMed
30.
Tabanca N, Kirimer N, Demirci F, Baser KH (2001) Composition and antimicrobial activity of the essential oil of Micromeria cristata subsp. phrygia and the enantiomeric distribution of borneol. J Agric Food Chem 49:4300–4003CrossRefPubMed
31.
Debat J, Lemoine J, Lier-Gabillot F (1981) Inula extract, its method of preparation and its use as pharmaceutical. US Patent 4254112.
32.
Caldes G, Prescott B, King JR (1975) Potential antileukemic substance present globularia alypum. Planta Med 27:72–76CrossRefPubMed
33.
Arrigoni PV (1979) Le genre Santolina L. en Italie. Webbia 34:257–264
34.
Marino M, Bersani C, Comi G (2001) Impedance measurements to study the antimicrobial activity of essential oils from Lamiaceae and Compositae. Int J Food Microbiol 67:187–195CrossRefPubMed
35.
Denyer SP, Hugo WB (1991) Biocide-induced damage to the bacterial cytoplasmic membrane. In: Denyer SP, Hugo WB (eds) Mechanisms of action of chemical biocides: their study and exploitation. Blackwell Scientific Publications, Oxford, United Kingdom, pp 171–187
36.
Hamouda T, Baker JR (2000) Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. J Applied Microbiol 89:397–403CrossRef
37.
Song MJ, Kim NM (2003) Antimicrobial action of p-hydroxyphenyl acrylate. Int Biodeterior Biodegradation 52:107–113CrossRef
38.
Razzaghi-Abyaneh M, Shams-Ghahfarokhi MK, Kawachi M, Eslamifar A, Schmidt OJ, Schmidt A, Allameh A, Yoshinari T (2006) Ultrastructural evidences of growth inhibitory effects of a novelbiocide, Akacids®plus, on an aflatoxigenic Aspergillus parasiticus. Toxicon 48:1075–1082CrossRefPubMed
39.
Horne DS, Holm M, Oberg C, Chao S, Young DG (2001) Antimicrobial effects of essential oils on Streptococcus pneumoniae. J Essent Oil Res 13:387–392
40.
Windholz M, Budavari S, Blumetti RF, Otterbein ES (1983) The Merck index, 10th edn. Merck & Co, Inc., Rahway, NJ
41.
Reichling J, Weseler A, Landvatter U, Saller R (2002) Bioactive essential oils used in phytomedicine as antiinfective agents: Australian tea tree oil and manuka oil. Acta Phytotherapeutica 1:26–32
42.
Maisner-Patin S, Richard J (1996) Cell wall changes in nisin-resistant variants of Listeria monocytogenes grown in the presence of high nisin concentrations. FEMS Microbiol Lett 140:29–35CrossRef
43.
Calderόn-Miranda ML, Barbosa-Cánovas GV, Swanson BG (1999) Transmission electron microscopy of Listeria monocytogenes treated by pulsed electric fields and nisin in skimmed milk. Int J Food Microbiol 51:31–38CrossRef
44.
Sikkema J, De Bont JAM, Poolman B (1994) Interactions of cyclic hydrocarbons with biological membranes. J Biol Chem 269:8022–8028PubMed
45.
Sikkema J, De Bont JAM, Poolman B (1995) Mechanism of membrane toxicity of hydrocarbons. Microbiol Rev 59:201–222PubMed
46.
Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG (2000) The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil). J Appl Microbiol 88:170–175CrossRefPubMed
47.
Ultee A, Bennink MJH, Moezelaar R (2002) The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogene Bacillus cereus. Appl Env Microbiol 68:1561–1568CrossRef
48.
Kalemba D, Kunicka A (2003) Antibacterial and antifungal properties of essential oils. Curr Med Chem 10:813–829CrossRefPubMed
49.
Cristani M, D'Arrigo M, Mandalari G, Castelli F, Sarpietro MG, Micieli D, Venuti V, Bisignano G, Saija A, Trombetta D (2007) Interaction of four monoterpenes contained in essential oils with model membranes: implications for their antibacterial activity. J Agric Food Chem 55:6300–6308CrossRefPubMed
Metadata
Title
Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus
Authors
E. Guinoiseau
A. Luciani
P. G. Rossi
Y. Quilichini
S. Ternengo
P. Bradesi
L. Berti
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 7/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0943-x

Other articles of this Issue 7/2010

European Journal of Clinical Microbiology & Infectious Diseases 7/2010 Go to the issue

Article

Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary

Article

Changing etiology of community-acquired bacterial meningitis in adults: a nationwide multicenter study in Korea

Brief Report

Introduction of an AmpR-L2 intergenic segment attenuates the induced β-lactamase activity of Stenotrophomonas maltophilia

Brief Report

Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China

Article

Superinfection during treatment of nosocomial infections with tigecycline

Review

Mycoviruses: future therapeutic agents of invasive fungal infections in humans?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits